Lemmer B, Charrier A
Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):205-12. doi: 10.1007/BF00505735.
The effects of phentolamine alone or in combination with propranolol, atenolol and chlorisondamine were studied on the concentration and turnover of noradrenaline in the heart of light-dark (L:D = 12:12 h) synchronized rats. In order to detect possible circadian phase-dependent variations in the drug effects, the same experiments were performed in the light-period and dark-period, respectively. The parameters of the turnover were calculated from the exponential decline of i.v. injected 3H-(-)-noradrenaline. Phentolamine significantly decreased the noradrenaline concentration during L, but not during D. Reduction in 3H-noradrenaline accumulation by phentolamine was 42.3% during L and 22.2% during D. Phentolamine increased the turnover rate of cardiac noradrenaline more than 3-fold in either photoperiod. Chlorisondamine reversed all the effects of phentolamine studied. Propranolol, but not atenolol, antagonized the effects of phentolamine in a dose-dependent and stereospecific way, being more effective when applied during D. Thus, the chronopharmacological studies in unrestrained rats show a circadian phase-dependency of the effects of adrenoceptor blocking drugs. It is concluded that a central site of action is responsible for the antagonism by propranolol of the phentolamine-induced increase in the turnover of the cardiac noradrenaline in vivo.
研究了酚妥拉明单独使用或与普萘洛尔、阿替洛尔和氯异吲哚铵联合使用对明暗(L:D = 12:12小时)同步化大鼠心脏中去甲肾上腺素浓度和周转率的影响。为了检测药物作用中可能存在的昼夜节律相位依赖性变化,分别在光照期和黑暗期进行了相同的实验。周转率参数根据静脉注射3H-(-)-去甲肾上腺素的指数下降来计算。酚妥拉明在光照期显著降低去甲肾上腺素浓度,但在黑暗期则不然。酚妥拉明在光照期使3H-去甲肾上腺素积累减少42.3%,在黑暗期减少22.2%。在任一光周期中,酚妥拉明使心脏去甲肾上腺素的周转率提高了3倍以上。氯异吲哚铵逆转了所研究的酚妥拉明的所有作用。普萘洛尔而非阿替洛尔以剂量依赖性和立体特异性方式拮抗酚妥拉明的作用,在黑暗期应用时更有效。因此,对自由活动大鼠的时辰药理学研究表明,肾上腺素能受体阻断药物的作用具有昼夜节律相位依赖性。得出的结论是,体内普萘洛尔对酚妥拉明诱导的心脏去甲肾上腺素周转率增加的拮抗作用是由一个中枢作用部位介导的。